Is the MVP regimen less active than previously described ? Results of a phase II study in advanced non-small cell lung cancerFERRIGNO, D; BUCCHERI, G.Acta oncologica (Stockholm). 1996, Vol 35, Num 4, pp 435-440, issn 0284-186X, 5 p.Article

Lumbar muscle metastasis from lung cancer. Report of a caseFERRIGNO, D; BUCCHERI, G.Acta oncologica (Stockholm). 1992, Vol 31, Num 6, pp 680-681, issn 0284-186XArticle

Monitoring lung cancer with tissue polypeptide antigen : an ancillary, profitable serum test to evaluate treatment response and posttreatment disease statusBUCCHERI, G; FERRIGNO, D.Lung cancer. 1995, Vol 13, Num 2, pp 155-168, issn 0169-5002Article

Clinical applications of serum markers for lung cancerFERRIGNO, D; BUCCHERI, G.Respiratory medicine. 1995, Vol 89, Num 9, pp 587-597, issn 0954-6111Article

A comprehensive evaluation of serum ferritin levels in lung cancer patientsFERRIGNO, D; BUCCHERI, G.Lung cancer. 1992, Vol 8, Num 2, pp 85-94, issn 0169-5002Article

Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancerBUCCHERI, G; FERRIGNO, D.Chest. 1988, Vol 93, Num 3, pp 565-570, issn 0012-3692Conference Paper

Lung cancer: clinical presentation and specialist referral timeBUCCHERI, G; FERRIGNO, D.The European respiratory journal. 2004, Vol 24, Num 6, pp 898-904, issn 0903-1936, 7 p.Article

Lung cancer in Borth-West Italy : demographic and clinical trends in a hospital-based population of 1277 patientsBUCCHERI, G; FERRIGNO, D.European journal of cancer prevention. 2003, Vol 12, Num 6, pp 455-461, issn 0959-8278, 7 p.Article

Lung tumour markers in oncology practice: a study of TPA and CA125BUCCHERI, G; FERRIGNO, D.British journal of cancer. 2002, Vol 87, Num 10, pp 1112-1118, issn 0007-0920, 7 p.Article

Prognostic value of the tissue polypeptide antigen in lung cancerBUCCHERI, G; FERRIGNO, D.Chest. 1992, Vol 101, Num 5, pp 1287-1292, issn 0012-3692Article

Second-line chemotherapy for recurrent non-small cell lung cancer : do new agents make a difference?FERRIGNO, D; BUCCHERI, G.Lung cancer. 2000, Vol 29, Num 2, pp 91-104, issn 0169-5002Article

Therapeutic options for regionally advanced non-small cell lung cancerBUCCHERI, G; FERRIGNO, D.Lung cancer. 1996, Vol 14, Num 2-3, pp 281-300, issn 0169-5002Article

The tissue polypeptide antigen serum test in the preoperative evaluation of non-small cell lung cancer : diagnostic yield and comparison with conventional staging methodsBUCCHERI, G; FERRIGNO, D.Chest. 1995, Vol 107, Num 2, pp 471-476, issn 0012-3692Article

A randomised trial of MACC chemotherapy with or without lonidamine in advanced non-small cell lung cancerBUCCHERI, G; FERRIGNO, D.European journal of cancer. Part A. 1994, Vol 30, Num 10, pp 1424-1431Article

Prognostic factors in lung cancer : tables and commentsBUCCHERI, G; FERRIGNO, D.The European respiratory journal. 1994, Vol 7, Num 7, pp 1350-1364, issn 0903-1936Article

Prognostic significance of blood coagulation tests in lung cancerFERRIGNO, D; BUCCHERI, G; RICCA, I et al.The European respiratory journal. 2001, Vol 17, Num 4, pp 667-673, issn 0903-1936Article

Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancerBUCCHERI, G; BIGGI, A; FERRIGNO, D et al.Thorax. 1996, Vol 51, Num 4, pp 359-363, issn 0040-6376Article

Serum tumour markers in lung cancer : history, biology and clinical applicationsFERRIGNO, D; BUCCHERI, G; BIGGI, A et al.The European respiratory journal. 1994, Vol 7, Num 1, pp 186-197, issn 0903-1936Article

A phase II study of methotrexate, doxorubicin, cyclophosphamide, and lomustine chemotherapy and lonidamine in advanced non-small cell lung cancerBUCCHERI, G; FERRIGNO, D; ROSSO, A et al.Cancer. 1993, Vol 72, Num 5, pp 1564-1572, issn 0008-543XArticle

Tissue polypeptide specific antigen (TPS) and objective response to treatment in solid tumorsMARINO, P; BUCCHERI, G; PREATONI, A et al.The International journal of biological markers. 1992, Vol 7, Num 1, pp 65-67, issn 0393-6155Article

Clinical value of a multiple biomarker assay in patients with bronchogenic carcinomaBUCCHERI, G. F; VIOLANTE, B; SARTORIS, A. M et al.Cancer. 1986, Vol 57, Num 12, pp 2389-2396, issn 0008-543XArticle

Karnofsky and ECOG performance status scoring in lung cancer : A prospective, longitudinal study of 536 patients from a single institutionBUCCHERI, G; FERRIGNO, D; TAMBURINI, M et al.European journal of cancer (1990). 1996, Vol 32, Num 7, pp 1135-1141, issn 0959-8049Article

Imaging lung cancer by scintigraphy with indium 111-labeled F(ab')2 fragments of the anticarcinoembryonic antigen monoclonal antibody FO23C5BUCCHERI, G; BIGGI, A; FERRIGNO, D et al.Cancer. 1992, Vol 70, Num 4, pp 749-759, issn 0008-543XArticle

Tumor markers in bronchogenic carcinoma: superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9BUCCHERI, G. F; FERRIGNO, D; SARTORIS, A. M et al.Cancer. 1987, Vol 60, Num 1, pp 42-50, issn 0008-543XArticle

Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancerBUCCHERI, G; FERRIGNO, D; VOLA, F et al.Lung cancer. 1993, Vol 10, Num 1-2, pp 21-33, issn 0169-5002Article